SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 91,300
-2,400 (-2.56%)
Last updated: Jul 4, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.16 trillion as of July 3, 2025. Its market cap has increased by 7.28% in one year.
Market Cap
7.16T
Enterprise Value
7.04T
Revenue
578.00B
Ranking
n/a
PE Ratio
28.49
Stock Price
91,300.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.16T, a decrease of -28.03%. That is a compound annual growth rate of -6.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 7,157.83B | -17.73% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.39T |
| Celltrion | 35.43T |
| ALTEOGEN | 19.91T |
| Yuhan | 7,801.88B |
| HLB Co., Ltd. | 6,571.71B |
| PharmaResearch | 4,955.86B |
| Peptron | 4,542.98B |
| LigaChem Biosciences | 4,143.62B |